Skip to main content
. 2019 Aug 8;4(8):13371–13381. doi: 10.1021/acsomega.9b01544

Figure 9.

Figure 9

MBs-RGD-ICG treatment (group 5M): fluorescence visualization following MBs-RGD-ICG injection of the (A) cranium, (B) chest cavity, and (C) peritoneal cavity.